Beren Therapeutics is a vertically integrated biopharmaceutical company focused on developing innovative therapies to address significant health challenges worldwide. Founded in 2020, the company aims to ensure that these therapies are accessible to all patients.

The company has gained recognition in the biotechnology sector and is currently in the clinical stage of development. Beren Therapeutics is engaged in creating highly innovative and efficacious therapies for various health conditions, including rare diseases. Their lead asset, BRN-002, has received an Innovation Passport under the United Kingdom's Innovative Licensing and Access Pathway (ILAP), which is designed to expedite the development of promising therapies.

Recently, Beren Therapeutics entered into a strategic investment and innovation agreement with Roquette, a global leader in plant-based ingredients and pharmaceutical excipients. This partnership is expected to enhance Beren's capabilities in developing and delivering its therapies effectively.

For more detailed information about Beren Therapeutics, you can explore the following resources:

1. Beren Therapeutics Press Release with Roquette - A press release detailing their recent partnership.
2. PitchBook Company Profile - A comprehensive look at Beren Therapeutics' business model and financials.
3. Crunchbase Profile - Overview of the company's funding and organizational details.
4. EveryLife Foundation for Rare Diseases - Information on Beren's involvement in the rare disease community.
5. VentureRadar Overview - Insights into the company's growth and clinical focus.
6. Beren's Innovation Award Announcement - Details about their expedited roadmap for BRN-002.
7. LinkedIn Announcement of the Agreement with Roquette - A professional summary of their strategic agreement.

Overall, Beren Therapeutics is positioning itself as an innovative player in the biotechnology landscape, particularly with its commitment to accessibility and rare disease solutions.

Sources

[PDF] BEREN THERAPEUTICS PRESS RELEASE - RoquetteBeren Therapeutics Company Profile 2024 - PitchBookBeren Therapeutics - Crunchbase Company Profile & Fundingberen therapeutics - EveryLife Foundation for Rare DiseasesBeren Therapeutics - VentureRadarBeren Awarded Expedited Roadmap for Treatment of Homozygous ...Innovation Agreement Roquette - Beren Therapeutics P.B.C - LinkedIn

Related Questions

Who is the CEO of Beren Therapeutics?

Where is Beren Therapeutics headquarters?

What does Beren Therapeutics do?